A MULTICENTER OBSERVATIONAL ASSESSMENT OF PLATELET TRANSFUSION IN NEONATAL INTENSIVE CARE UNITS
Main Article Content
Keywords
Neonatology, Platelet Transfusion, Thrombocytopenia, Neonatal Intensive Care Unit, Prematurity, Multicenter Study, Sindh
Abstract
Background: Platelet transfusion is a widely employed therapeutic intervention in Neonatal Intensive Care Units (NICUs), particularly among preterm and critically ill neonates. Current evidence suggests that factors beyond thrombocytopenia alone often influence transfusion decisions, underscoring the need for context-specific data to inform evidence-based guidelines.
Objective: This multicenter observational study aimed to evaluate the incidence, clinical determinants, and indications for platelet transfusions among neonates admitted to NICUs across multiple tertiary care hospitals in Sindh, Pakistan.
Methodology: A prospective cohort study design was employed across selected tertiary care hospitals in Sindh over a five-month period. All neonates consecutively admitted to the NICUs during the study timeframe were included. Clinical, demographic, and laboratory data were extracted through comprehensive chart reviews. A structured, validated questionnaire was administered to assess the underlying justifications for each platelet transfusion episode.
Results & Findings: A total of 401 neonates were enrolled. The mean birth weight (BW) was 2.34 ± 1.01 kg, and the mean gestational age (GA) was 34.4 ± 4.5 weeks. Platelet transfusions were administered to 37 neonates (9.2%). The majority of transfused neonates were either extremely preterm (<28 weeks; 40.5%) or term (≥37 weeks; 24.3%). The median pre-transfusion platelet count was 57 × 10⁹/L (range: 9–285 × 10⁹/L). Compared to their non-transfused counterparts, transfused neonates exhibited significantly lower BW and GA, elevated CRIB-II and SNAPPE-II scores (all p<0.001), and were more frequently admitted due to respiratory distress (p<0.001), hypoxic-ischemic encephalopathy (p=0.009), and hemolytic disease of the newborn (p<0.001). Multivariate logistic regression identified gestational age <28 weeks (p<0.001), mechanical ventilation (p=0.008), and platelet nadir ≤150 × 10⁹/L at admission (p<0.001) as independent predictors of transfusion. The primary clinical indications cited for the initial platelet transfusion were thrombocytopenia (86.5%), underlying disease pathology (78.4%), and severity of illness (37.8%).
Conclusion: This multicenter analysis highlights substantial inter-patient variability in pre-transfusion platelet counts, with transfusion decisions frequently exceeding guideline-recommended thresholds. Beyond thrombocytopenia, multiple clinical parameters—particularly prematurity, respiratory compromise, and disease severity—emerged as significant determinants of transfusion practices. These findings underscore the necessity for standardized, evidence-based transfusion protocols tailored to the unique clinical settings of resource-limited neonatal care environments.
References
2. Christensen RD, Henry E, Wiedmeier SE, et al. Thrombocytopenia among extremely low birth weight neonates: Data from a multihospital healthcare system. J Perinatol 2006;26(6):348–53.
3. Andrew M, Castle V, Saigal S, Carter C, Kelton JG. Clinical impact of neonatal thrombocytopenia. J Pediatr 1987;110(3):457–64.
4. Andrew M, Vegh P, Caco C, et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993;123(2):285–91.
5. von Lindern JS, van den Bruele T, Lopriore E, Walther FJ. Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: A retrospective cohort study. BMC Pediatr 2011;11:16.
6. Baer VL, Lambert DK, Henry E, Christensen RD. Severe thrombocytopenia in the NICU. Pediatrics 2009;124(6):e1095–100.
7. Stanworth SJ, Clarke P, Watts T, et al. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009;124(5):e826–34.
8. Sparger K, Deschmann E, Sola-Visner M. Platelet transfusions in the neonatal intensive care unit. Clin Perinatol 2015;42(3):613–23.
9. von Lindern JS, Hulzebos CV, Bos AF, Brand A, Walther FJ, Lopriore E. Thrombocytopaenia and intraventricular haemorrhage in very premature infants: A tale of two cities. Arch Dis Child Fetal Neonatal Ed 2012;97(5):F348–52.
10. Baer VL, Lambert DK, Henry E, Snow GL, Sola- Visner MC, Christensen RD. Do platelet transfusions in the NICU adversely affect survival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system. J Perinatol 2007;27(12):790–6.
11. Kenton AB, Hegemier S, Smith EO, et al. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity. J Perinatol 2005;25(3):173–77.
12. Dohner ML, Wiedmeier SE, Stoddard RA, et al. Very high users of platelet transfusions in the neonatal intensive care unit. Transfusion 2009;49(5):869–72.
13. Baer VL, Lambert DK, Henry E, Snow GL, Christensen RD. Red blood cell transfusion of preterm neonates with a Grade 1 intraventricular hemorrhage is associated with extension to a Grade 3 or 4 hemorrhage. Transfusion 2011;51(9):1933–9.
14. Bilgin YM, van de Watering LMG, Versteegh MIM, van Oers MHJ, Vamvakas EC, Brand A. Postoperative complications associated with transfusion of platelets and plasma in cardiac surgery. Transfusion 2011;51(12):2603–10.
15. Curley A, Stanworth SJ, Willoughby K, et al. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med 2019;380(3):242–51.
16. Narayan S, Poles D, Bellany M, et al. On behalf of the Serious Hazards of Transfusion (SHOT) Steering Group. The 2018 Annual SHOT Report 2019.
17. Fustolo-Gunnink SF, Fijvandraat K, van Klaveren D, et al. Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death. Blood 2019;134(26):2354–60.
18. Josephson CD, Su LL, Christensen RD, et al. Platelet transfusion practices among neonatologists in the United States and Canada: Results of a survey. Pediatrics 2009;123(1):278–85.
19. Sparger KA, Assmann SF, Granger S, et al. Platelet transfusion practices among very-low-birth-weight infants. JAMA Pediatr 2016;170(7):687–94.
20. Patel RM, Hendrickson JE, Nellis ME, et al. Variation in neonatal transfusion practice. J Pediatr 2021;235:92–9.e4.
21. Parry G, Tucker J, Tarnow-Mordi W; UK Neonatal Staffing Study Collaborative Group. CRIB II: An update of the clinical risk index for babies score. Lancet 2003;361(9371):1789–91.
22. Richardson DK, Corconan JD, Escobar GJ, Lee SK. SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores. J Pediatr 2001;138(1):92–100.
23. Del Vecchio A, Sola MC, Theriaque DW, et al. Platelet transfusions in the neonatal intensive care unit: Factors predicting which patients will require multiple transfusions. Transfusion 2001;41(6):803–8.
24. Murray NA, Roberts IAG. Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed 2004;89(2):F101–7.
25. Norfolk D, editor. Handbook of Transfusion Medicine. United Kingdom Blood Services. 5ed. Sheffield: The Stationary Office; 2013. p.170.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Maliha Asif
Associate Professor, Department of Pathology, Rahbar Medical and Dental College, Lahore, Pakistan.
Mubashir Raza
Consultant Pediatrician RHQ Hospital, Skardu, Pakistan.
Abdur Raziq
District Children Specialist Women and Children Hospital Kohat, Pakistan.
Arshad Ali lakho
Assistant Professor, Pediatric Medicine PUMHS-W Nawabshah, Pakistan.
Mohammad Shahid Iqbal
Department of Pediatrics, Benazir Bhutto Hospital Rawalpindi, Pakistan.
Maryam Raza
Consultant Hematologist, National Institute of Child Health, Karachi, Pakistan.
Mubeen Younas
Lab Manager, Bajwa hospital, Govt Teaching hospital Shahdara Lahore, Pakistan.